Asian Spectator


The Times

.

Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc

  • Written by PR Newswire Asia - Asian Spectator

Australian scientists who discovered how to "turn off" genes that make cancer cells grow are celebrating the next phase of development – with Pfizer's first in class KAT6 inhibitor PF-07248144 now moving to the next stages of clinical investigation.

MELBOURNE, Australia, Sept. 15, 2025 /PRNewswire/ -- Australian biotechnology investment and...

Magazine

Compressed Air Pipe and Fittings: What Every Australian Industrial Facility Needs to Know

Compressed air is the fourth utility of modern industry, right alongside electricity, gas, and water. Yet despite its critical role in powering everything from pneumatic tools to automated productio...

Common Risks Hidden in Commercial Lease Agreements

Commercial leases are often longer and more complex than tenants expect, and the fine print can carry significant financial and operational consequences over the years that follow. Many business own...

Corporate Secretarial Services in Singapore: Annual Compliance, Key Filings, and Common Mistake

Annual compliance in Singapore should not be treated as a once-a-year administrative event. It is an ongoing governance system that depends on accurate records, timely filings, disciplined approvals...

hacklink hack forum hacklink film izle hacklink z-librarygrandpashabet giriş güncel girişgrandpashabet casino grandpashabetskorbettelegram webpashagaming girişcasibomjojobettelegram ifşadeneme bonusubetwoonagen bolacasibomnakitbahistelegram下载jojobetjojobetjojobetdeneme bonusungsbahis